BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38759453)

  • 21. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
    Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W
    Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and bioevaluation of 2,7-diaryl-pyrazolo[1,5-a]pyrimidines as tubulin polymerization inhibitors.
    Liu R; Zhang S; Huang M; Guo Z; Li L; Li M; Wu L; Guan Q; Zhang W
    Bioorg Chem; 2021 Oct; 115():105220. PubMed ID: 34352709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance.
    Liu Z; Yang Z; Ablise M
    Bioorg Chem; 2024 Jun; 147():107310. PubMed ID: 38583249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel diaryl-2H-azirines: Antitumor hybrids for dual-targeting tubulin and DNA.
    Lin S; Liang Y; Cheng J; Pan F; Wang Y
    Eur J Med Chem; 2021 Mar; 214():113256. PubMed ID: 33581556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.
    Wang G; Liu W; Fan M; He M; Li Y; Peng Z
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1694-1702. PubMed ID: 34309466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
    Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
    Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production.
    Tang H; Liang Y; Cheng J; Ding K; Wang Y
    Eur J Med Chem; 2021 Oct; 221():113531. PubMed ID: 34044345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4.
    Sun J; Chen L; Liu C; Wang Z; Zuo D; Pan J; Qi H; Bao K; Wu Y; Zhang W
    Chem Biol Drug Des; 2015 Dec; 86(6):1541-7. PubMed ID: 26202587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and antitumor evaluation of novel chiral diaryl substituted azetidin-2-one derivatives as tubulin polymerization inhibitors.
    Liang Y; Zhang M; Zhou P; Liu M; Li J; Wang Y
    Bioorg Chem; 2021 Oct; 115():105239. PubMed ID: 34399321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and bio-evaluation of novel 2-aryl-4-(3,4,5-trimethoxy-benzoyl)-5-substituted-1,2,3-triazoles as the tubulin polymerization inhibitors.
    Huang L; Liu M; Man S; Ma D; Feng D; Sun Z; Guan Q; Zuo D; Wu Y; Zhang W; Bao K
    Eur J Med Chem; 2020 Jan; 186():111846. PubMed ID: 31740055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
    Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
    J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic bridged analogs of isoCA-4: Design, synthesis and biological evaluation.
    Pecnard S; Provot O; Levaique H; Bignon J; Askenatzis L; Saller F; Borgel D; Michallet S; Laisne MC; Lafanechère L; Alami M; Hamze A
    Eur J Med Chem; 2021 Jan; 209():112873. PubMed ID: 33038796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and biological evaluation of 1-substituted -2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents.
    Li L; Quan D; Chen J; Ding J; Zhao J; Lv L; Chen J
    Eur J Med Chem; 2019 Dec; 184():111732. PubMed ID: 31610372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel 1-indolyl acetate-5-nitroimidazole derivatives of combretastatin A-4 as potential tubulin polymerization inhibitors.
    Yao YF; Wang ZC; Wu SY; Li QF; Yu C; Liang XY; Lv PC; Duan YT; Zhu HL
    Biochem Pharmacol; 2017 Aug; 137():10-28. PubMed ID: 28456516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents.
    Sun WX; Ji YJ; Wan Y; Han HW; Lin HY; Lu GH; Qi JL; Wang XM; Yang YH
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4066-4074. PubMed ID: 28757065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.
    Xu S; An B; Li Y; Luo X; Li X; Jia X
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities.
    Ren Y; Ruan Y; Cheng B; Li L; Liu J; Fang Y; Chen J
    Bioorg Med Chem; 2021 Sep; 46():116376. PubMed ID: 34455231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
    Kamal A; Shaik B; Nayak VL; Nagaraju B; Kapure JS; Shaheer Malik M; Shaik TB; Prasad B
    Bioorg Med Chem; 2014 Oct; 22(19):5155-67. PubMed ID: 25192811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent combretastatin A-4 analogs containing 1,2,4-triazole: Synthesis, antiproliferative, anti-tubulin activity, and docking study.
    Mustafa M; Anwar S; Elgamal F; Ahmed ER; Aly OM
    Eur J Med Chem; 2019 Dec; 183():111697. PubMed ID: 31536891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.